Comparison of Treatment Retention Between Risperidone Long-Acting Injection and First-Generation Long-Acting Injections in Patients With Schizophrenia for 5 Years

被引：3
|
作者：
Suzuki, Hidenobu [1 ]
Hibino, Hiroyuki [2 ]
Inoue, Yuichi [3 ]
Takaya, Atsuhiko [2 ]
机构：
[1] Suzuki Clin, Dept Psychiat, Tokyo, Japan
[2] Fukui Kinen Hosp, Dept Psychiat, Yokohama, Kanagawa, Japan
[3] Shakomae Kokorono Clin, Dept Psychiat, Tokyo, Japan
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 04期
关键词：
D O I：
10.1097/JCP.0000000000000533
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：405 / 406
页数：3
相关论文
共 50 条
  • [11] Treatment effectiveness and adherence in patients with schizophrenia treated with risperidone long-acting injection
    Chang, Chen-Lin
    Tzeng, Dong-Sheng
    Lung, For-Wey
    PSYCHIATRY RESEARCH, 2010, 180 (01) : 16 - 19
  • [12] Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder
    Wu, Chi-Shin
    Hsieh, Ming H.
    Tang, Chao-Hsiun
    Chang, Ching-Jui
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 197 : 189 - 195
  • [13] Effectiveness of long-acting risperidone for patients with treatment refractory schizophrenia
    Kimura, H.
    Kanahara, N.
    Komasu, N.
    Ishige, M.
    Muneoka, K.
    Yoshimura, M.
    Yamanaka, H.
    Suzuki, T.
    Watanabe, H.
    Sekine, Y.
    Iyo, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 53 - 54
  • [14] Patients with schizophrenia prefer long-acting injections
    Hovens, JE
    Roman, B
    Van Dinther, R
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 84 - 84
  • [15] The cost-effectiveness of risperidone long-acting injection in the treatment of schizophrenia
    Chue, Pierre
    Chue, James
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 259 - 269
  • [16] Long-term benefits of treatment with risperidone long-acting injection (LAI) in patients with schizophrenia
    Turner, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 71 - 71
  • [17] Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain - a cost-effectiveness comparison
    Dilla, Tatiana
    Moeller, Joergen
    O'Donohoe, Paul
    Alvarez, Maria
    Sacristan, Jose A.
    Happich, Michael
    Tockhorn, Antje
    BMC PSYCHIATRY, 2014, 14
  • [18] Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
    Catalan, Rosa
    Penades, Rafael
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 95 - 105
  • [19] Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
    Tatiana Dilla
    Jörgen Möller
    Paul O’Donohoe
    María Álvarez
    José A Sacristán
    Michael Happich
    Antje Tockhorn
    BMC Psychiatry, 14
  • [20] Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone
    Olfson, Mark
    Marcus, Steven C.
    Ascher-Svanum, Haya
    SCHIZOPHRENIA BULLETIN, 2007, 33 (06) : 1379 - 1387
12345